Methionine Enhances the Contractile Activity of Human Colon Circular Smooth Muscle In Vitro

다국어 초록 (Multilingual Abstract)

Effective drug to manage constipation has been unsatisfactory. We sought to determine whether methionine has effect on the human colon. Human colon tissues were obtained from the specimens of colon resection. Microelectrode recording was performed and contractile activity of muscle strips and the propagation of the contractions in the colon segment were measured. At 10 μM, methionine depolarized the resting membrane potential (RMP) of circular muscle (CM) cells. In the CM strip, methionine increased the amplitude and area under the curve (AUC) of contractions. In the whole segment of colon,methionine increased the amplitude and AUC of the high amplitude contractions in the CM. These effects on contraction were maximal at 10 μM and were not observed in longitudinal muscles in both the strip and the colon segment. Methionine reversed the effects of pretreatment with sodium nitroprusside, tetrodotoxin and Nw-oxide-L-arginine,resulting in depolarization of the RMP, and increased amplitude and AUC of contractions in the muscle strip. Methionine treatment affected the wave pattern of the colon segment by evoking small sized amplitude contractions superimposed on preexisting wave patterns.

Our results indicate that a compound mimicking methionine may provide prokinetic functions in the human colon.

참고문헌 (Reference)

1 Milo R, "Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome" 6 : 577-584, 1980

2 Degen L, "Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects" 15 : 1745-1751, 2001

3 Prather CM, "Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome" 118 : 463-468, 2000

4 Koh SD, "TREK-1 regulation by nitric oxide and cGMP-dependent protein kinase. An essential role in smooth muscle inhibitory neurotransmission" 276 : 44338-44346, 2001

5 Brandt LJ, "Systematic review on the management of chronic constipation in North America" 100 : S5-S21, 2005

6 Park KJ, "Sulfur-containing amino acids block stretch-dependent K+ channels and nitrergic responses in the murine colon" 144 : 1126-1137, 2005

7 Stipanuk MH, "Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine" 24 : 539-577, 2004

8 Koh SD, "Stretch-dependent potassium channels in murine colonic smooth muscle cells" 533 : 155-163, 2001

9 Spiller R, "Serotonergic modulating drugs for functional gastrointestinal diseases" 54 : 11-20, 2002

10 McCallum RW, "Review of the current status of prokinetic agents in gastroenterology" 80 : 1008-1016, 1985

11 Schoenfeld P, "Review article: the safety profile of tegaserod" 2 : 25-30, 2004

12 Karamanolis G, "Promotility medications: now and in the future" 24 : 297-307, 2006

13 Reynolds JC, "Prokinetic agents: a key in the future of gastroenterology" 18 : 437-457, 1989

14 Longo WE, "Prokinetic agents for lower gastrointestinal motility disorders" 36 : 696-708, 1993

15 Reynolds JC, "Prokinetic agents" 21 : 567-596, 1992

16 Gupta MP, "Phospholipid N-methylation-dependent alterations of cardiac contractile function by L-methionine" 245 : 664-672, 1988

17 Ward SM, "Nonadrenergic, noncholinergic inhibition and rebound excitation in canine colon depend on nitric oxide" 262 : G237-G243, 1992

18 Sanders KM, "Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission" 2 : G379-G392, 1992

19 Bailey LD Jr, "New directions in the irritable bowel syndrome" 20 : 335-349, 1991

20 Panagia V, "Methionine-induced positive inotropic effect in rat heart: possible role of phospholipid N-methylation" 62 : 51-55, 1988

21 Kihara Y, "L-methionine augments mammalian myocardial contraction by sensitizing the myofilament to Ca2+" 77 : 80-87, 1995

22 Hogeveen M, "Hyperhomocysteinemia as risk factor for ischemic and hemorrhagic stroke in newborn infants" 141 : 429-431, 2002

23 Hasler WL, "Gastroparesis: symptoms, evaluation, and treatment" 36 : 619-647, 2007

24 Herbst F, "Gastrointestinal transit and prolonged ambulatory colonic motility in health and faecal incontinence" 41 : 381-389, 1997

25 Lacy BE, "Gastrointestinal motility disorders: an update" 24 : 228-242, 2006

26 Burrin DG, "Emerging aspects of gut sulfur amino acid metabolism" 10 : 63-68, 2007

27 Danielsson BR, "Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs" 24 : 42-56, 2007

28 Sanger GJ, "Effects of metoclopramide and domperidone on cholinergically mediated contractions of human isolated stomach muscle" 37 : 661-664, 1985

29 Wiley J, "Dopaminergic modulation of rectosigmoid motility: action of domperidone" 242 : 548-551, 1987

30 Prakash A, "Domperidone. A review of its use in diabetic gastropathy" 56 : 429-445, 1998

31 Coremans G, "Cisapride stimulates propulsive motility patterns in human jejunum" 33 : 1512-1519, 1988

32 Bright-Asare P, "Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux" 2 : 149-156, 1980

33 Rao SS, "Ambulatory 24-h colonic manometry in healthy humans" 280 : G629-G639, 2001